Medpharmics, LLC

Albuquerque, New Mexico 87102

0 studies enrolling now · 8 studies all time

What they study most

COVID-19 Prevention, Infant Development, Lower Respiratory Tract Disease, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19, Pneumococcal Disease, Respiratory Syncytial Virus Infections, Respiratory Syncytial Viruses, SARS-CoV-2

Studies at this site

• A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
• A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age — Completed
• A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
• MVA-BN-RSV Vaccine Trial — Stopped early
• Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age — Completed
• Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas — Completed
• Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination — Completed